Asmanex (mometasone furoate inhalation powder) is an inhaled corticosteroid (ICS). Continual use of Asmanex helps manage asthma symptoms in patients with persistent asthma. Additionally, its automatic dose counter helps patients track remaining doses.
Robert Spiegel, chief medical officer and senior vice president, Schering-Plough Research Institute, said: “As the first inhaled corticosteroid that is approved for once-daily dosing in children as young as age four, the approval of the pediatric indication for Asmanex provides an important treatment option for children with moderate and mild persistent asthma.”